Renovis Surgical Technologies said today it won FDA 510(k) clearance for its Tesera lumbar porous titanium interbody fusion systems.

The Redlands, Calif.-based company said its newly cleared Tesera devices feature implants designed for direct posterior or transforaminal approaches, and includes straight and curved options in multiple heights, widths and lengths.

The Tesera devices are produced using 3D printing techniques and feature the company’s Tesera trabecular technology designed to improve bone attachment and the potential for biologic fixation, according to a press release.

Renovis said the clearance is the 5th for the company.

See the best minds in medtech live at DeviceTalks Boston on Oct. 2.